Evidence map›Paper›PMID 38193325›Full record

ArticleJournal of Korean medical science2024

Safety of COVID-19 Vaccination During Pregnancy and Lactation: A VigiBase Analysis.

Dayeon Kang, Ahhyung Choi, Suneun Park, Seung-Ah Choe, Ju-Young Shin

Open access · goldAbstract read
In one paragraph

Article in Journal of Korean medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Dayeon Kang *Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Korea.ORCID https://orcid.org/0009-0007-5731-6734
Ahhyung Choi *School of Pharmacy, Sungkyunkwan University, Suwon, Korea.ORCID https://orcid.org/0000-0002-0101-7328
Suneun ParkSchool of Pharmacy, Sungkyunkwan University, Suwon, Korea.ORCID https://orcid.org/0009-0000-4703-322X
Seung-Ah ChoeDepartment of Preventive Medicine, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-6270-5020
Ju-Young ShinDepartment of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Korea.ORCID https://orcid.org/0000-0003-1010-7525
Sungkyunkwan University · KRKorea University · KRSamsung (South Korea) · KR

Funding

Ministry of Food and Drug Safety 22153MFDS607Ministry of Food and Drug Safety 22183MFDS433
6 · The paper itself

Abstract

backgroundThere is limited evidence on the safety of coronavirus disease 2019 (COVID-19) vaccination during pregnancy and lactation. Thus, we aimed to evaluate the association between COVID-19 vaccination during pregnancy and lactation and reporting risk of adverse pregnancy or lactation outcomes.

methodsUsing VigiBase, we performed a disproportionality analysis with case/non case design. Cases were defined based on the Standardized MedDRA Queries (SMQs) of "pregnancy and neonatal topics" and non-cases were defined as all other adverse events. We included all reports with COVID-19 vaccines as the suspected cause. Using the full database as the comparators, reporting odds ratios (RORs) with 95% confidence intervals (CIs) were estimated by logistic regression while adjusting for maternal age. Infants' age and sex were additionally adjusted in analyzing the risk of COVID-19 vaccination during lactation.

resultsWe identified 10,266 and 6,474 reports with the SMQ of "pregnancy and neonatal topics" associated with COVID-19 vaccines during pregnancy and lactation, respectively. No significant RORs of adverse pregnancy outcomes associated with COVID-19 vaccines during pregnancy were observed; however, "functional lactation disorders" showed significant disproportionality during lactation with adjusted ROR of 1.48 (95% CI, 1.21-1.79). Further analysis that analyzed "functional lactation disorders" at a preferred term level, showed higher ROR in mastitis (2.76 [95% CI, 1.45-5.27]).

conclusionOverall, we did not observe a positive association between COVID-19 vaccination during pregnancy and risk of reporting adverse pregnancy outcomes. However, we found a significant disproportionate reporting association between COVID-19 vaccination during lactation and "functional lactation disorders", specifically mastitis. Continuous surveillance is warranted to confirm the safety of COVID-19 vaccine during pregnancy and lactation.

Indexed as

COVID-19 VaccinesLactationCOVID-19FemaleHumansInfantInfant, NewbornLactation DisordersMaleMastitisPregnancyVaccinationCOVID-19 VaccinesAdverse Pregnancy OutcomesCOVID-19 VaccinePregnancyVigiBase

Identifiers

PMID38193325
PMCPMC10782038
OpenAlexW4389155437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.